AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

169.500

-1.710-1.00%

Volume:1.09M

Turnover:184.05M

Market Cap:81.18B

PE:-22.68

High:170.190

Open:169.660

Low:166.680

Close:171.210

52wk High:216.748

52wk Low:88.836

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.06

T/O Rate:0.23%

Dividend:4.08

Dividend Rate:2.41%

EPS(TTM):-7.474

EPS(LYR):-7.474

ROE:-15.83%

ROA:7.26%

PB:3.93

PE(LYR):-22.68

Loading ...

Overview Company News Filings

Commonwealth Bank Stock And 2 Australian Dividend Shares Worth A Closer Look

Simply Wall St.

Csl's Latest Blow Supports Continued Caution

Market Chatter: Carlisle Companies Made Unsolicited Offers for Owens Corning

MT Newswires Live

CSL to Cease New Patient Initiation for Tavneos in EU and Eea Markets

CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe

MT Newswires Live

To Provide Details on Tavneos Ip Impairment in 2026 Full Year Results

THOMSON REUTERS

Expects FY26 Tavneos Sales Revenue of About $145 Mln

THOMSON REUTERS

To Cease New Patient Initiation for Tavneos in EU and Eea Markets

THOMSON REUTERS

Ema Chmp Recommends Revocation of EU Marketing Authorisation for Tavneos on Jun 26

THOMSON REUTERS

Commonwealth Bank Stock And 2 ASX Dividend Shares Paying More Than 3%

Simply Wall St.

Chmp Recommends Revoking Marketing Authorisation for Tavneos® (avacopan) in the European Union

THOMSON REUTERS

EU Commission Opens Antitrust Probe into Sanofi's Flu Vaccine Campaign

Sanofi Spokesperson on EU Probe: Cooperating Fully with the European Commission Throughout the Process

THOMSON REUTERS

Sanofi Spokesperson on EU Probe: Sanofi is Confident That it Has Acted, and Continues to Act, in Full Compliance with All Applicable Laws and Regulations

THOMSON REUTERS

Commonwealth Bank Stock And 2 Australian Dividend Shares For Steady Income

Simply Wall St.

Is Rising Institutional Interest in Carlisle (CSL) Reframing Its Resilience Narrative Despite Softer Results?

Simply Wall St.

CSL, Plasma Industry Could Continue to Grow Strongly for Considerable Period, Jefferies Says

MT Newswires Live

US Military Requires Flu Vaccine for Some After Outbreak in Texas Training Center

3 Australian Income Stocks With Dividend Yield And Profit Margin Risk

Simply Wall St.

Is CSL’s (ASX:CSL) Trading Surge and Restructuring Reviving Confidence in Its Core Business Model?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/CSL.AU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":169.5,"timestamp":1789020720000,"preClose":171.21,"halted":0,"volume":1090729,"delay":0,"changeRate":-0.009987734361310717,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.47394596406918,"marketStatus":"Not Yet Opened","change":-1.71,"latestTime":"09-10 16:12:00 AEST","open":169.66,"high":170.19,"low":166.68,"amount":184052300,"amplitude":0.020501,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.47394596406918,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":171.21,"dividendRate":0.02404,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":1.0589420996301422,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":169.5,"auctionPrice":169,"auctionVolume":1103,"auctionTime":1789077543025,"referenceTime":1789036203090,"auction":1,"marketStatus":"盘前竞价","timestamp":1789077543025}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.473946,"volumeRatio":1.0589420996301422,"shares":478911979,"dividePrice":4.079238,"high":170.19,"amplitude":0.020501,"preClose":171.21,"low":166.68,"week52Low":88.836,"pbRate":"3.93","psRate":"3.68","week52High":216.748,"institutionHeld":0,"latestPrice":169.5,"eps":-7.47394596406918,"divideRate":0.024066,"volume":1090729,"delay":0,"ttmEps":-7.47394596406918,"open":169.66,"prevYearClose":168.21,"prevWeekClose":172.243,"prevMonthClose":169.351,"prevQuarterClose":113.256,"fiveDayClose":173.23,"twentyDayClose":135.741,"sixtyDayClose":106.682,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647814495","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2647814495","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647814495?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:13","pubTimestamp":1782785612,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses can appeal when inflation, interest rates and consumer confidence are all in flux, as they are today. With policy paths diverging across the US, Europe and Asia, many investors are looking for income streams that are both sizeable and supported by stable cash flows. The Dividend Powerhouses (3%+ Yield) screener focuses on companies that pay a higher yield, with dividends that are covered and have a record of stability. This article highlights 3 stocks from that screener,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-wor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-wor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK7104","BK7135","CSL.AU","QFN.AU","STW.AU","VAS.AU","CBA.AU","BK4588","SLF.AU","GOAU","DACE.AU","IISV.AU","OZR.AU","BEGS","IOZ.AU","EIGA.AU","IMLC.AU","BEAR.AU","BBOZ.AU","GLTR","QRE.AU","BK7067","BK7508","BK7501","CEF","BK7506","E200.AU","XME","VIG","OZF.AU","EVN.AU","XAO.AU","ZYAU.AU","GIVE.AU","BK7511","GBUG","XKO.AU","GEAR.AU","VAP.AU","PICK","BK4585","UYM","IIGF.AU","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588908","title":"Csl's Latest Blow Supports Continued Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588908","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647588908?lang=en_us&edition=fundamental","pubTime":"2026-06-30 07:56","pubTimestamp":1782777360,"startTime":"0","endTime":"0","summary":"2356 GMT - The almost certain withdrawal of the CSL-marketed Tavneos therapy in Europe only adds to Macquarie's caution toward the Australian biotechnology company. An analyst at the investment bank tells clients in a note that a European Commission ruling on the treatment appears to be a formality, and trims EPS forecasts by 3% for fiscal 2027 and by 4% for fiscal 2028. The analyst reiterates a neutral rating on the stock and reminds readers of the significant near-term earnings uncertainty across CSL's core business segments, plus ongoing medium-term competitive risks. Target price rises 2.7% to 114.00 Australian dollars, reflecting currency moves. Shares are at A$115.39 ahead of the open.  Dow Jones NewswiresJune 29, 2026 19:56 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647459306","title":"Market Chatter: Carlisle Companies Made Unsolicited Offers for Owens Corning","url":"https://stock-news.laohu8.com/highlight/detail?id=2647459306","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647459306?lang=en_us&edition=fundamental","pubTime":"2026-06-30 01:24","pubTimestamp":1782753884,"startTime":"0","endTime":"0","summary":"Carlisle Companies  has made multiple unsolicited offers to acquire Owens Corning , with a potential deal valued at over $10 billion, The Wall Street Journal reported Monday, citing people familiar with the matter.Owens Corning has not yet engaged substantially with Carlisle, the report said, adding that Carlisle is now evaluating its next move.Carlisle Companies, Owens Corning did not immediately respond to MT Newswires' request for comment.Price: 369.68, Change: -18.70, Percent Change: -4.81","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","LU0728928796.USD","LU1548497426.USD","LU2048586759.USD","BK4512","LU1720051108.HKD","LU1992135472.HKD","CNAV","LU0868494617.USD","LU2106854487.HKD","LU2357305700.SGD","GLWG","LU2272731865.HKD","LU0348723411.USD","LU2272731600.USD","BK4588","BK7508","LU2298321311.HKD","LU1974910355.USD","IE00BGHQF417.EUR","BK4086","LU2473716301.USD","BK7067","LU1917777945.USD","SGXZ23171101.USD","GLW","LU1720051017.SGD","LU2322448957.HKD","LU1169590202.USD","BK7511","CSL","BK4585","LU2543165471.USD","BK4148","OC","LU2092937221.SGD","IE00B3CCJ633.GBP","SG9999004303.SGD","IE00B2PGVK34.USD","BK7501","LU2023250843.SGD","LU2272731782.SGD","LU2322448791.USD","LU1992135399.USD","LU2360108059.USD","CSL.AU","IE00BFMHRM44.USD","LU2041044095.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647344990","title":"CSL to Cease New Patient Initiation for Tavneos in EU and Eea Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2647344990","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647344990?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:27","pubTimestamp":1782696438,"startTime":"0","endTime":"0","summary":"BRIEF-CSL To Cease New Patient Initiation For Tavneos In EU And Eea MarketsJune 29 -CSL LtdCSL.AX:TO CEASE NEW PATIENT INITIATION FOR TAVNEOS IN EU AND EEA MARKETSEMA CHMP RECOMMENDS REVOCATION OF EU MARKETING AUTHORISATION FOR TAVNEOS ON JUN 26TO PROVIDE DETAILS ON TAVNEOS IP IMPAIRMENT IN 2026 FULL YEAR RESULTSEXPECTS FY26 TAVNEOS SALES REVENUE OF ABOUT $145 MILLIONFurther company coverage:CSL.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN42Y121:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7508","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647334151","title":"CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2647334151","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647334151?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:22","pubTimestamp":1782692567,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued an opinion recommending the revocation of the European Union marketing authorization","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4087","CSL.AU","BK7067","BK7511","SG9999004303.SGD","CSL","LU1169589451.USD","LU0728928796.USD","EPV","LU1169590202.USD","EEA","BK4086","SGXZ23171101.USD","BK7501","CHMP","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534917","title":"To Provide Details on Tavneos Ip Impairment in 2026 Full Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647534917?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7067","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647494883","title":"Expects FY26 Tavneos Sales Revenue of About $145 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2647494883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647494883?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","CSL.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349179","title":"To Cease New Patient Initiation for Tavneos in EU and Eea Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349179?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7508","BK7067","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349176","title":"Ema Chmp Recommends Revocation of EU Marketing Authorisation for Tavneos on Jun 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349176?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7508","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343252","title":"Commonwealth Bank Stock And 2 ASX Dividend Shares Paying More Than 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343252","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647343252?lang=en_us&edition=fundamental","pubTime":"2026-06-29 01:14","pubTimestamp":1782666848,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses are attracting fresh attention as investors weigh mixed signals across global markets, from shifting inflation expectations in the US and Europe to changing rate paths in Mexico, Brazil, and Japan. With bond yields moving and growth data sending a patchwork of signals, many income focused investors are looking at companies that pay more than a 5% dividend yield that is well covered, growing, and stable. This article highlights three stocks from the Dividend Powerhouses...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-asx-dividend-shares-paying-mor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-asx-dividend-shares-paying-mor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DULL","PHYS","XKO.AU","CEF","AGIX","CBA.AU","GLL","DZZ","CHAT","AAAU","PICK","GDX","VIG","FGDL","DUST","USG","BEGS","KGLD","BTGD","GBUG","UGL","CSL.AU","IAUI","XME","BAR","EVN.AU","GDXY","SGOL","JNUG","SGDM","SHNY","UYM","OUNZ","XJO.AU","RING","IAUM","GDXD","GOLY","XAO.AU","GLDM","AIPO","IAU","DBC","GLTR","ARTY","GDXJ","GDXU","GOAU","DGP","JDST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646508653","title":"Chmp Recommends Revoking Marketing Authorisation for Tavneos® (avacopan) in the European Union","url":"https://stock-news.laohu8.com/highlight/detail?id=2646508653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646508653?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:00","pubTimestamp":1782478802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUA8Y3PLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7067","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646305359","title":"EU Commission Opens Antitrust Probe into Sanofi's Flu Vaccine Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2646305359","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646305359?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:34","pubTimestamp":1782470088,"startTime":"0","endTime":"0","summary":"UPDATE 1-EU Commission opens antitrust probe into Sanofi's flu vaccine campaignAdds Sanofi reaction in paragraphs 4-5BRUSSELS, June 26 (Reuters)-The European Commission opened an investigation on Frid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL8N42Y0LC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646561793","title":"Sanofi Spokesperson on EU Probe: Cooperating Fully with the European Commission Throughout the Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2646561793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646561793?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:18","pubTimestamp":1782469123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nB5N41C02P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7511","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646178356","title":"Sanofi Spokesperson on EU Probe: Sanofi is Confident That it Has Acted, and Continues to Act, in Full Compliance with All Applicable Laws and Regulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2646178356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646178356?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:18","pubTimestamp":1782469123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nB5N41C02P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7067","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646455333","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares For Steady Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2646455333","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646455333?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:15","pubTimestamp":1782440138,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and central bank moves pulling markets in different directions, many investors are looking for income that feels more dependable than short term price swings. That is where Dividend Powerhouses with a 5%+ yield, solid coverage and a track record of stable, growing payouts can help anchor a portfolio. This article looks at the Dividend Powerhouses (3%+ Yield) screener and highlights three of the stronger stocks it identifies, illustrating how consistently funded...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VAP.AU","BEAR.AU","NST.AU","XAO.AU","QRE.AU","IIGF.AU","IOZ.AU","CHAT","GIVE.AU","QFN.AU","IISV.AU","XKO.AU","AIPO","BK7501","CBA.AU","CSL.AU","SLF.AU","IMLC.AU","VIG","BK7506","EIGA.AU","BK4585","DACE.AU","BK7508","ZYAU.AU","STW.AU","OZF.AU","BK7511","AGIX","BBOZ.AU","BK7067","GEAR.AU","BK4588","BK7135","BK7104","VAS.AU","E200.AU","OZR.AU","ARTY","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646877186","title":"Is Rising Institutional Interest in Carlisle (CSL) Reframing Its Resilience Narrative Despite Softer Results?","url":"https://stock-news.laohu8.com/highlight/detail?id=2646877186","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646877186?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:21","pubTimestamp":1782386485,"startTime":"0","endTime":"0","summary":"In recent weeks, Carlisle Companies has attracted heightened attention as strong institutional ownership, favorable analyst rankings and multiple technical buy signals have emerged despite a year-over-year revenue decline of around 4% and an approximate 11% drop in net profit. \nThis mix of robust professional interest and improving earnings expectations, even amid softer reported results, is reshaping how investors view Carlisle’s balance between resilience and risk. \nWe’ll now examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/is-rising-institutional-interest-in-carlisle-csl-reframing-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/is-rising-institutional-interest-in-carlisle-csl-reframing-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","BK7508","ARTY","BK7511","CHAT","BK4086","BK7067","AIPO","LU1169589451.USD","LU1169590202.USD","LU0728928796.USD","CSL","CSL.AU","SGXZ23171101.USD","BK7501","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646157826","title":"CSL, Plasma Industry Could Continue to Grow Strongly for Considerable Period, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2646157826","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646157826?lang=en_us&edition=fundamental","pubTime":"2026-06-25 12:08","pubTimestamp":1782360498,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) and the plasma industry could continue to grow strongly for a considerable period, Jefferies said in a Thursday note.The plasma industry is treating at most 34% of the total potential pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999004303.SGD","BK7508","LU1169590202.USD","SGXZ23171101.USD","BK7501","LU1169589451.USD","CSL","BK4086","BK7511","LU0728928796.USD","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646810729","title":"US Military Requires Flu Vaccine for Some After Outbreak in Texas Training Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2646810729","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646810729?lang=en_us&edition=fundamental","pubTime":"2026-06-25 02:26","pubTimestamp":1782325600,"startTime":"0","endTime":"0","summary":"US military requires flu vaccine for some after outbreak in Texas training centerJune 24 (Reuters)-The U.S. military has resumed requiring flu vaccines for some service members in an exception to Defe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nL4N42W1F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1301847155.USD","LU0857590862.USD","LU2112291526.USD","LU1057294990.SGD","LU1989771016.USD","IE0002141913.USD","LU2468319806.SGD","LU0211327993.USD","LU1261432733.SGD","LU1496350502.SGD","LU2089284900.SGD","LU0526926950.USD","LU0972486137.USD","LU0289739699.SGD","LU0997586515.USD","LU0792757196.USD","LU1104425308.USD","LU0545039389.USD","LU1267930813.SGD","IE00BFTCPJ56.SGD","LU0757432116.USD","LU2357627491.SGD","LU0960981461.USD","LU0827474353.SGD","LU1119994496.HKD","LU2279689827.SGD","LU1829250122.USD","LU1355424745.HKD","LU0784385170.HKD","LU0047473722.EUR","LU2237443978.SGD","LU0128525929.USD","LU0887340254.USD","LU0128525689.USD","AZN.UK","LU0949170426.SGD","LU0784383803.USD","LU1267930490.SGD","LU0047473722.SGD","LU2125909593.SGD","03165","LU1061106388.HKD","LU1084165304.USD","LU0122379950.USD","LU0499090636.EUR","IE00BKPKM643.USD","CSL.AU","LU1983299246.USD","LU1989772923.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645010288","title":"3 Australian Income Stocks With Dividend Yield And Profit Margin Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2645010288","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645010288?lang=en_us&edition=fundamental","pubTime":"2026-06-22 09:20","pubTimestamp":1782091254,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses can be useful when you want your portfolio to work for you through regular cash income as well as potential capital gains. With central banks watching inflation, energy markets influencing bond yields and consumers showing mixed strength across regions from Canada to Malaysia, many investors are paying closer attention to companies that pay solid, well covered dividends. This Dividend Powerhouses screener focuses on stocks with yields above 5% that are supported by stable...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-income-stocks-with-dividend-yield-and-profit-ma","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-income-stocks-with-dividend-yield-and-profit-ma","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GBUG","CBA.AU","XKO.AU","VIG","DACE.AU","BK4535","SLF.AU","BEGS","OZR.AU","XAO.AU","BK7508","EVN.AU","UYM","VAS.AU","BK7067","BBOZ.AU","IOZ.AU","GLTR","XJO.AU","GEAR.AU","XME","GIVE.AU","QFN.AU","BK4588","BK7135","CSL.AU","GOAU","BK7501","CEF","E200.AU","IIGF.AU","BK7104","IMLC.AU","OZF.AU","PICK","QRE.AU","BEAR.AU","BK4585","EIGA.AU","IISV.AU","BK7511","STW.AU","ZYAU.AU","VAP.AU","BK7506"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645215010","title":"Is CSL’s (ASX:CSL) Trading Surge and Restructuring Reviving Confidence in Its Core Business Model?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645215010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645215010?lang=en_us&edition=fundamental","pubTime":"2026-06-22 07:22","pubTimestamp":1782084151,"startTime":"0","endTime":"0","summary":"CSL has recently attracted renewed investor attention after a difficult period marked by earnings downgrades, operational issues across its plasma and vaccine businesses, restructuring moves, and leadership uncertainty.\nThis shift in sentiment has coincided with heavy trading activity, a rotation toward defensive healthcare names, and anticipation around CSL’s upcoming full-year results and dividend announcement.\nWe’ll now explore how this rebound in interest, amid elevated trading volumes...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csls-asxcsl-trading-surge-and-restructuring-reviving-conf","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csls-asxcsl-trading-surge-and-restructuring-reviving-conf","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARTY","CSL","LU1169590202.USD","SG9999004303.SGD","LU0728928796.USD","CSL.AU","AGIX","BK7067","SGXZ23171101.USD","LU1169589451.USD","AIPO","BK7511","CHAT","BK7508","BK4086","BK7501"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}